View metadata
| dc.title | Breve 11: Value Based Drug Reimbursement: Introduction to the Main Features of the German Pharmaceutical Policy |
| dc.contributor.author | Inter-American Development Bank |
| dc.contributor.orgunit | Social Protection and Health Division |
| dc.coverage | Germany |
| dc.date.available | 2016-07-18T00:00:00 |
| dc.date.issue | 2016-07-15T00:00:00 |
| dc.description.abstract | This Breve is based on a webinar presented by Dr. Wolfgang Greiner, professor at the University of Bielefeld, member of the scientific Advisorygroup of the German Institute for Quality and Efficiency in Health Care (IQWiG)and the EuroQol group. The presentation was delivered on September 29, 2015, to the members of CRITERIA, the Knowledge Network on Health Benefits Packages and Priority Setting in Health at the Inter-American Development Bank. |
| dc.identifier.doi | http://dx.doi.org/10.18235/0007991 |
| dc.identifier.url | https://publications.iadb.org/publications/english/document/Breve-11-Value-Based-Drug-Reimbursement-Introduction-to-the-Main-Features-of-the-German-Pharmaceutical-Policy.pdf |
| dc.language.iso | en |
| dc.medium | Adobe PDF |
| dc.publisher | Inter-American Development Bank |
| dc.relation.series | Criteria Network |
| dc.subject | Health Services |
| dc.subject | Innovation |
| dc.subject | Cost-Benefit Analysis |
| dc.subject | Health Expenditure |
| dc.subject.keywords | health care services, health care systems, health expenditures, health insurance, pharmaceutical, German |
| dc.type | Learning Materials |
| idb.identifier.pubnumber | Learning Materials |
| idb.operation | RG-T1759 |